Clinical Trial Update: Bifeprunox in the Treatment of Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of bifeprunox for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Bifeprunox (bifeprunox)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED